Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific announced in March that it entered into a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire Lumenis’ surgical business, which develops and commercializes energy-based medical solutions. […]
Report: Two vaccine leaders set to step down from FDA
Two senior vaccine leaders within the FDA are reportedly relinquishing their positions within the administration. According to a report from Endpoints News, which cites a letter released internally to FDA staff first reported on by BioCentury, Marion Gruber and Phil Krause will depart in the coming months due to frustrations over the delegation of certain decisions within some governing […]
Zimmer Biomet touts data supporting its MyMobility with Apple Watch
Zimmer Biomet (NYSE:ZBH) today touted data highlighting the clinical value of its MyMobility platform with Apple Watch. Warsaw, Indiana-based Zimmer Biomet announced four data presentations on MyMobility with Apple Watch, which it touts as a first-of-its-kind remote care management platform for helping healthcare professionals remotely support and guide patients during their preparation for and recovery from […]
Abbott touts Amplatzer Amulet results in head-to-head trial with Boston Scientific’s Watchman
Abbott (NYSE:ABT) is claiming a big win for its Amplatzer Amulet device in a head-to-head trial with Boston Scientific’s (NYSE:BSX) Watchman. Late-breaking data presented at the European Society of Cardiology Congress and simultaneously published in Circulation support the FDA’s recent approval for the Amplatzer Amulet, Abbott said in a news release. The Amplatzer Amulet Left Atrial […]
Overcoming vaccine delivery device design’s top challenges
Vaccine delivery has long been a hot topic and only got hotter in the ongoing push to vaccinate against COVID-19 around the world. Most would probably associate vaccines with the standard “jab” injection with a syringe. Over the past year and more, companies have touted ideas for other avenues. Inovio has a “smart” delivery device for […]
Fresenius Medical Care investing $25M in Humacyte as it goes public in SPAC deal
Fresenius Medical Care announced today that it will invest $25 million in Humacyte in connection with the merger of Humacyte and a SPAC. Humacyte, which develops implantable human acellular vessels for multiple vascular repair, reconstruction and replacement, entered into a merger with a special purpose acquisition company (SPAC), leading Fresenius to increase its position in […]
Bioventus triggers $50M option to acquire CartiHeal
Bioventus (NSDQ:BVS) announced today that it chose to make a $50 million escrow payment to acquire CartiHeal and its Agili-C implant. Durham, N.C.-based Bioventus elected to make its escrow payment pursuant to its option and equity purchase agreement with CartiHeal to signal its intent to move forward with an acquisition of the company. According to […]
Hillrom stock skyrockets amid reports that Baxter is close to acquisition
Baxter (NYSE:BAX) is reportedly in advanced talks to acquire Hillrom (NYSE:HRC) for approximately $10 billion. The Wall Street Journal reported yesterday that the talks were ongoing at an advanced stage. WSH previously reported on rumblings of a potential deal last month. Hillrom’s stock shot up when that report came out, and it’s rising again today, […]
Smith+Nephew touts analysis of Oxinium in total hip arthroplasty
Smith+Nephew (NYSE:SNN) today touted its Oxinium technology as the best performing bearing with the lowest revision risk in total hip arthroplasty. London Based S+N shared results substantiated by four national and regional joint registries over the last 20 years, covering more than 2 million procedures from which to draw, according to a news release. The […]
Zimmer Biomet, Canary Medical win FDA de novo nod for smart knee implant
Zimmer Biomet (NYSE:ZBH) and Canary Medical announced today that the FDA granted de novo classification for Persona IQ. The de novo grant and marketing authorization comes for the tibial extension for Persona IQ, which the companies tout as the first and only smart knee implant cleared by the FDA for total knee replacement surgery. (Canary […]
MedTech 100 roundup: Industry reaches another high point
The medtech industry is continuing its massive 2021 boom, with the past week marking yet another record in the markets. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 27) at 121.05 points, representing a 1.2% rise from the 119.63-point mark set a week before. […]